Trial Profile
Effect of moderate liver impairment on the pharmacokinetics of saquinavir after administration of saquinavir/ritonavir 1000/100mg BID in HIV patients.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Saquinavir (Primary) ; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Roche
- 20 Jan 2010 Status changed from active, no longer recruiting to completed as reported by Roche.
- 20 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 17 Jun 2008 The expected completion date for this trial has been extended from Jun 2009 to May 2010 as reported by ClinicalTrials.gov